<DOC>
	<DOCNO>NCT02709577</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy EndoBarrier Gastrointestinal Liner compare sham control subject Type 2 diabetes .</brief_summary>
	<brief_title>A Study GI Sleeve Treatment Type 2 Diabetes</brief_title>
	<detailed_description>The study design randomize , single blind , sham control , pilot efficacy study subject Type 2 diabetes enrol 2 center Santiago , Chile . Subjects enrol 2:1 ratio ( EndoBarrier sham ) . Following implantation sham procedure , subject treat 24 week 52 week . Following explant , subject follow additional 8-12 week . Subject evaluation include measurement HbA1c , glucose , insulin , weight , change diabetic medication , meal tolerance test . Safety monitor collection clinical lab , physical assessment , endoscopy adverse event .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Age &gt; 18 year &lt; 55 year Male Female Patients type 2 diabetes , treat 10 year less HbA1c level ≥ 7.0 ≤ 10.0 % Fasting glucose ≤ 240 mg/dl Patients take metformin , sulfonylureas thiazolidinediones ( TZDs ) , either alone combination BMI &gt; 30 &lt; 50 Patients willing comply study requirement Patients sign informed consent form Women postmenopausal , surgically sterile , oral contraceptive least three month plan become pregnant course study . Patients take oral medication control diabetes sulfonylurea , metformin thiazolidinediones Patients diagnose type 1 diabetes mellitus history ketoacidosis Patients require insulin Patients lab evidence probable insulin production failure ( fast C peptide serum level &lt; 1ng/ml ) Patients weight loss &gt; 10 lb within three month screen Patients require prescription anticoagulation therapy Patients iron deficiency iron deficiency anemia Patients history abnormal pathology GI tract Patients know gallstone kidney stone prior implant Known infection time implant Severe coagulopathy , upper gastrointestinal bleeding condition esophageal gastric varix , congenital acquire intestinal telangiectasia Pregnant intention become pregnant next 12 month Patients history active kidney stone Mentally retard emotionally unstable , exhibit psychological characteristic , opinion investigator , make subject poor candidate device placement clinical trial Previous GI surgery could affect ability place sleeve function implant Patients unable discontinue NSAIDs ( nonsteroidal antiinflammatory drug ) implant period H. pylorus positive patient ( Note : patient may enrol prior history successfully treat ) Patients receive weight loss medication Meridia Xenical Family patient history know diagnosis preexist symptom systemic lupus erythematous , scleroderma autoimmune connective tissue disorder Patients Gastrointestinal Reflux Disease ( GERD ) Participating another ongoing investigational clinical trial Patients take corticosteroid drug know affect gastrointestinal motility ( reglan )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>